Crossmark

Impurity profiling HPLC–UV/PDA method development, validation and relative response factor estimation for budesonide, glycopyrronium and formoterol fumarate combination product

Crossref DOI link: https://doi.org/10.1007/s44371-025-00366-x

Published Online: 2025-11-19

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Kulkarni, Shrikant V. https://orcid.org/0000-0002-1842-0826
Korhale, Rasika R. https://orcid.org/0000-0001-9893-2540
Musmade, Bhaskar D. https://orcid.org/0000-0002-1188-9947
Bhope, Shrinivas G. https://orcid.org/0000-0002-1723-8002
Nagar, Mitesh https://orcid.org/0009-0005-4633-0210
Panchgalle, Sharad P. https://orcid.org/0000-0001-9706-7567
More, Vijaykumar S. https://orcid.org/0000-0002-6110-8774
License Information

Text and Data Mining valid from 2025-11-19

Version of Record valid from 2025-11-19
More Information

Article History

Received: 8 June 2025

Accepted: 13 November 2025

First Online: 19 November 2025

Declarations

:

: Not applicable.

: Not applicable.

: The authors declare no competing interests.